J. Veselka

J. Veselka, D. Zemánek, J. Honěk, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Three-dimensional echocardiography in the diagnosis of fast-moving intracardiac formations

J. Veselka, J. Fiedler, M. Šetina, 2008 .

The "edge effect" after implantation of beta-emitting (55Co) stents with high initial activity.

J. Veselka, J. Štursa, M. Costa, 2004, Acta medica.

Multiple mobile aortic thrombosis treated by thrombolysis. A case report

J. Veselka, J. Fiedler, V. Durdil, 2007, Journal of Thrombosis and Thrombolysis.

Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.

M. Penicka, J. Veselka, P. Widimsky, 2009, Genetic testing and molecular biomarkers.

The role of tissue factor in thrombosis and hemostasis.

J. Veselka, P. Hájek, P. Tomašov, 2007, Physiological research.

Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo Evaluation

J. Falck, J. Veselka, P. Kala, 2021, Biomedicines.

Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and Ren-2 Transgenic Hypertensive Rats

V. Melenovský, J. Veselka, P. Kala, 2021, International journal of molecular sciences.

Lack of an association between connexin-37, stromelysin-1, plasminogen activator-inhibitor type 1 and lymphotoxin-alpha genes and acute coronary syndrome in Czech Caucasians.

M. Aschermann, M. Penicka, V. Lánská, 2010, Experimental and clinical cardiology.

Proteomic analysis of plasma samples from acute coronary syndrome patients - the pilot study.

J. Veselka, P. Májek, J. Dyr, 2012, International journal of cardiology.

Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins

J. Veselka, P. Hájek, P. Tomašov, 2011, Archives of medical science : AMS.

Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test

J. Veselka, T. Honěk, D. Tesař, 2002, Coronary artery disease.

Patients with acute coronary syndromes have low tissue factor activity and microparticle count, but normal concentration of tissue factor antigen in platelet free plasma – a pilot study

J. Veselka, P. Hájek, P. Tomašov, 2009, European journal of haematology.

Long-term survival of carotid stenting patients with regard to single- or double-vessel carotid artery disease: a propensity score matching analysis

J. Veselka, P. Hájek, R. Roland, 2020, Archives of medical science : AMS.

Carotid artery stenting without post-dilation.

J. Veselka, P. Zimolová, M. Špaček, 2012, Journal of interventional cardiology.

Spectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathy

M. Penicka, J. Veselka, P. Widimsky, 2012, Acta cardiologica.

Lack of Efficacy of Ticlopidine Pre−Treatment in the Reduction of Troponin I Release Following Percutaneous Intervention in Stable Angina Patients

J. Veselka, H. Veselka, 2005 .

Effectiveness of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with late gadolinium enhancement on cardiac magnetic resonance.

J. Veselka, J. T. ten Berg, E. Poláková, 2020, International journal of cardiology.

Genetic determination of the prognosis in survivors of acute coronary syndromes. Study design and rationale for a multicenter study

J. Pitha, M. Aschermann, M. Penicka, 2007 .

Comparison of sublingual isosorbide dinitrate and Valsalva maneuver for detection of obstruction in hypertrophic cardiomyopathy

J. Veselka, T. Kara, P. Tomašov, 2015, Archives of medical science : AMS.

(Complex approach towards patients with hypertrophic cardiomyopathy and indications to genetic testing)

J. Kautzner, M. Macek, J. Veselka, 2020 .

Effect of MGuard net protective stent on the release of troponin I in patients with acute coronary syndromes. A randomized controlled trial.

J. Veselka, P. Hájek, P. Tomašov, 2011, International heart journal.

Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy.

M. Penicka, J. Veselka, P. Tomašov, 2014, Folia biologica.

Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis.

H. Bundgaard, R. Stables, J. Veselka, 2019, European heart journal.

Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)

M. Macek, J. Veselka, P. Hájek, 2010, Trials.

Transcatheter aortic valve implantation in patient with cardiogenic shock

J. Veselka, P. Hájek, T. Butta, 2018 .

Ticlopidine Treatment Before Percutaneous Coronary Intervention in Patients With Stable Angina Pectoris

J. Veselka, D. Tesař, Ingrid Bolomová, 2003 .

Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.

J. Veselka, P. Hájek, D. Zemánek, 2009, The American journal of cardiology.

Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.

J. Veselka, P. Hájek, P. Tomašov, 2011, The American journal of cardiology.

New Developments in Hypertrophic Cardiomyopathy.

J. Veselka, N. Anavekar, C. Raphael, 2017, The Canadian journal of cardiology.

Use of intravascular ultrasound in procedures involving the left main coronary artery

J. Veselka, P. Hájek, D. Zemánek, 2010 .

Mid-term outcomes of patients with Lotus and Evolut transcatheter valves

J. Veselka, P. Hájek, E. Poláková, 2022, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Effect of impaired cardiac conduction after alcohol septal ablation on clinical outcomes: Insights from the Euro-ASA registry.

H. Bundgaard, J. Veselka, J. T. ten Berg, 2018, European heart journal. Quality of care & clinical outcomes.

Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.

H. Bundgaard, J. Veselka, J. T. ten Berg, 2017, JACC. Cardiovascular interventions.

Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.

H. Bundgaard, J. Veselka, J. T. ten Berg, 2016, European heart journal.

Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.

J. Veselka, J. Krejčí, P. Tomašov, 2015, The Canadian journal of cardiology.

Survival of patients ≤ 50 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

J. Veselka, M. Branny, J. Krejčí, 2014, The Canadian journal of cardiology.

Historical milestones and progress in the research on alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

J. Veselka, 2014, The Canadian journal of cardiology.

Low incidence of procedure-related major adverse cardiac events after alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.

J. Veselka, M. Branny, J. Krejčí, 2013, The Canadian journal of cardiology.

Clinical Research Low Incidence of Procedure-Related Major Adverse Cardiac Events After Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy

J. Veselka, M. Branny, J. Krejčí, 2013 .

Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective

J. Veselka, P. Tomašov, D. Zemánek, 2009, Heart and Vessels.

Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a single-center prospective, and randomized study.

J. Veselka, D. Zemánek, P. Červinka, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Treatment of a large left main coronary artery thrombus by aspiration thrombectomy

J. Veselka, P. Hájek, K. Linhartová, 2009, Journal of Thrombosis and Thrombolysis.

Effect of rosuvastatin therapy on troponin I release following percutaneous coronary intervention in nonemergency patients (from the TIP 3 study).

J. Veselka, P. Hájek, M. Branny, 2014, The American journal of cardiology.

Combined percutaneous treatment of atrial septal defect and pulmonic or aortic stenosis in adult patients

J. Veselka, P. Tomašov, K. Linhartová, 2010, Archives of medical science : AMS.

Balloon aortic valvuloplasty - a forgotten method or hope for the high-risk elderly patient?

J. Veselka, K. Linhartová, R. Duchoňová, 2008 .

Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.

H. Bundgaard, R. Stables, J. Veselka, 2021, International journal of cardiology.

Correction to: Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain

G. Feuchtner, M. Gutberlet, L. Saba, 2020, Health and Quality of Life Outcomes.

Uncomplicated Pregnancy in a Patient Treated With Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.

J. Veselka, P. Tomašov, R. Chmel, 2017, The Canadian journal of cardiology.

Head-Up Tilt Test in Risk Stratification of Patients with Hypertrophic Cardiomyopathy

J. Veselka, T. Hnat, J. Bonaventura, 2019, International Journal of Angiology.

Head-Up Tilt Test in Risk Strati ﬁ cation of Patients with Hypertrophic Cardiomyopathy

J. Veselka, T. Hnat, J. Bonaventura, 2019 .

Alcohol septal ablation in patients with severe septal hypertrophy

H. Bundgaard, J. Veselka, J. T. ten Berg, 2019, Heart.

(Atypical manifestation of Takotsubo syndrome during COPD exacerbation)

J. Veselka, M. Jenšovský, Kateřina Pelechová, 2021, Cor et Vasa.

Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension

J. Veselka, P. Kala, M. Táborský, 2022, Journal of hypertension.

Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation.

R. Stables, J. Veselka, P. Hansen, 2022, JACC. Cardiovascular interventions.

Coronary artery anomalies — a short review

J. Veselka, D. Zemánek, 2007 .

Direct stenting without predilatation: a new approach to coronary intervention

M. Aschermann, J. Veselka, M. Mates, 2000, Coronary artery disease.

Screening and Risk Stratification Strategy Reduced Decompression Sickness Occurrence in Divers With Patent Foramen Ovale.

J. Veselka, M. Brabec, L. Šefc, 2021, JACC. Cardiovascular imaging.

Claudication pain in the left arm of a coronary artery bypass graft patient using crutches: Coronary subclavian steal syndrome - a case report.

J. Veselka, M. Špaček, 2010, The International journal of angiology : official publication of the International College of Angiology, Inc.

Long-term health outcome and mortality evaluation after invasive coronary treatment using drug-eluting stents: HOME DES registry

J. Veselka, P. Kala, P. Červinka, 2007, Coronary artery disease.

“Head‐to‐head comparison between sirolimus‐eluting and paclitaxel‐eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study”

J. Veselka, D. Angiolillo, M. Costa, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The impact of education as a marker of socio-economic status on survival of patients after transcatheter aortic valve implantation

J. Veselka, P. Hájek, R. Adlová, 2022, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Predictors of long-term survival in patients treated with targeted temperature management after cardiac arrest

J. Veselka, M. Pavlíková, J. Bonaventura, 2019, Archives of medical science : AMS.

Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation

H. Bundgaard, J. Veselka, J. T. ten Berg, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: a randomized study with a follow-up up to 11 years.

J. Veselka, P. Tomašov, D. Zemánek, 2011, The Canadian journal of cardiology.

Obesity paradox in female patients after stent implantation for carotid artery disease.

J. Veselka, Ingrid Homolová, P. Zimolová, 2014, International journal of cardiology.

Sudden death risk stratification in hypertrophic cardiomyopathy

J. Veselka, D. Zemánek, S. Homolová, 2009 .

How to Treat Obstructions in Patients with Hypertrophic Cardiomyopathy

J. Veselka, 2015, International Journal of Angiology.

J. Veselka, P. Hájek, D. Zemánek, 2006, Circulation journal : official journal of the Japanese Circulation Society.

Management of Massive Pulmonary Embolism.

J. Veselka, E. Polaková, 2022, The International journal of angiology : official publication of the International College of Angiology, Inc.

Comparison of 30-Day Outcomes after Carotid Artery Stenting in Patients with Near-Occlusion and Severe Stenosis: A Propensity Score Matching Analysis

J. Veselka, P. Hájek, M. Horváth, 2022, American Journal of Neuroradiology.

Presence of the viral genome in the myocardial tissue of patients without clinical suspicion of myocarditis.

P. Hubáček, J. Veselka, D. Zemánek, 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

High positive predictive value of PAPP-A for acute coronary syndrome diagnosis in heparin-naïve patients

M. Macek, J. Veselka, P. Hájek, 2012, Journal of Thrombosis and Thrombolysis.

Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes.

J. Veselka, P. Sorajja, D. Tesař, 2005, The American journal of cardiology.

The time has come to move from coronary angiography to physiological assessment of coronary lesions

J. Veselka, 2013, Archives of medical science : AMS.

Pitfalls of anticoagulation therapy in pregnant women with mechanical valve prostheses. The case of two thrombotic events during one pregnancy

J. Veselka, David Alan, Jiří Vejvoda, 2019, Cor et Vasa.

Prediction of Sudden Cardiac Arrest After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: ASA-SCARRE Risk Score.

R. Stables, J. Veselka, P. Hansen, 2022, American Journal of Cardiology.

TAVI-in-TAVI in a patient after alcohol septal ablation

J. Veselka, P. Hájek, R. Adlová, 2021, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Update on alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

J. Veselka, J. Bonaventura, E. Polaková, 2019, Kardiologia polska.

Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long‐Term Follow‐Up Study Based on the Euro‐Alcohol Septal Ablation Registry

H. Bundgaard, R. Stables, J. Veselka, 2017, Journal of the American Heart Association.

Twenty years of alcohol septal ablation document more than a history of a single interventional procedure

J. Veselka, 2015 .

Early outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy

J. Veselka, J. Sitar, M. Branny, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy?

J. Veselka, L. Riedlbauchová, J. Janoušek, 2013, The Journal of invasive cardiology.

Management of Hypertrophic Obstructive Cardiomyopathy with a Focus on Alcohol Septal Ablation

J. Veselka, 2012 .

Management of hypertrophic obstructive cardiomyopathy with a focus on interventional therapy

J. Veselka, 2012 .

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Is it safe?

J. Veselka, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety.

J. Veselka, 2007, Swiss medical weekly.

Effects of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy on Doppler Tei Index: A Midterm Follow‐Up

J. Veselka, D. Tesař, Šárka Procházková, 2005, Echocardiography.

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome

J. Veselka, P. Červinka, T. Honěk, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.

J. Veselka, T. Honěk, 2003, International journal of cardiology.

Ten Tips and Tricks for Performing Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy

J. Veselka, 2020, International Journal of Angiology.

Obstruction after alcohol septal ablation is associated with cardiovascular mortality events

J. Veselka, J. Krejčí, P. Tomašov, 2016, Heart.

New and existing risk factors in patients with hypertrophic cardiomyopathy.

J. Veselka, M. Jensen, M. Marel, 2015, The Canadian journal of cardiology.

Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.

J. Veselka, P. Tomašov, D. Zemánek, 2015, International journal of cardiology.

Editorial New and Existing Risk Factors in Patients With Hypertrophic Cardiomyopathy

J. Veselka, M. Jensen, M. Marel, 2015 .

Outcome of patients after alcohol septal ablation with permanent pacemaker implanted for periprocedural complete heart block.

J. Veselka, J. Krejčí, P. Tomašov, 2014, International journal of cardiology.

Outcome of patients ≥ 60 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathy

J. Veselka, J. Krejčí, P. Tomašov, 2019, Archives of medical science : AMS.

Treatment of recurrent coronary rupture by implantation of three coronary stent-grafts

J. Veselka, T. Honěk, D. Tesař, 2003, International journal of cardiovascular interventions.

Combined percutaneous approach for aortic valve implantation in poor vascular access.

P. Hajek, J. Veselka, P. Kala, 2020, Bratislavske lekarske listy.

Improvement of left ventricular diastolic function after alcohol septal ablation for obstructive hypertrophic cardiomyopathy? Yes, of course, but...

J. Veselka, 2006, European heart journal.

Consequences of impressive myectomy results in a Center of Excellence: The paradox of evidence-based medicine era.

J. Veselka, 2019, American heart journal.

Low procedure-related mortality achieved with alcohol septal ablation in European patients.

H. Bundgaard, J. Veselka, P. Hansen, 2016, International journal of cardiology.

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.

J. Veselka, 2007, Medical science monitor : international medical journal of experimental and clinical research.

Early opening of dormant septal collaterals during alcohol septal ablation: a possible hazard of remote necrosis.

J. Veselka, P. Tomašov, D. Zemánek, 2013, The Canadian journal of cardiology.

The anomalous origin of the left coronary artery from the right aortic sinus: is the coronary angiography still a ‘gold standard’?

J. Veselka, D. Zemánek, D. Tesař, 2006, The International Journal of Cardiovascular Imaging.

Patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation have favorable long-term outcome irrespective of their genetic background.

M. Macek, J. Veselka, J. Bonaventura, 2020, Cardiovascular diagnosis and therapy.

Atherosclerotic Plaque Composition Is Still an Almost Unrecognized Factor of Risk Stratification in Patients with Carotid Artery Disease.

J. Veselka, 2015, The International journal of angiology : official publication of the International College of Angiology, Inc.

Anomalous origin of the right coronary artery from the pulmonary trunk: Is surgical reimplantation into the aorta a method of choice?

J. Kautzner, J. Veselka, J. Kautzner, 1996, Clinical cardiology.

Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: Studies in 5/6 nephrectomized rats with aorto-caval fistula.

J. Veselka, P. Kala, M. Táborský, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A comprehensive interdisciplinary view at the Return to Sport after COVID-19 infection.

M. Šafář, J. Veselka, J. Beran, 2021, Vnitrni lekarstvi.

Mutations in NEBL encoding the cardiac Z-disk protein nebulette are associated with various cardiomyopathies

A. Angelini, J. Veselka, S. Sperling, 2016, Archives of medical science : AMS.

MicroRNA-331 and microRNA-151-3p as biomarkers in patients with ST-segment elevation myocardial infarction

J. Veselka, P. Hájek, L. Šenolt, 2020, Scientific Reports.

A FTO variant and risk of acute coronary syndrome.

J. Pitha, M. Aschermann, M. Penicka, 2010, Clinica chimica acta; international journal of clinical chemistry.

Anomalous Origin of the Right Coronary Artery from the Pulmonary Trunk:

J. Kautzner, J. Veselka, 1994 .

Genetic Testing in Patients with Hypertrophic Cardiomyopathy

J. Veselka, V. Vejtasova, J. Bonaventura, 2021, International journal of molecular sciences.

The utility of the Mayo Score for predicting the yield of genetic testing in patients with hypertrophic cardiomyopathy

M. Macek, J. Veselka, P. Tomašov, 2018, Archives of medical science : AMS.

Variants in miRNA Regulating Cardiac Growth Are Not a Common Cause of Hypertrophic Cardiomyopathy

J. Veselka, P. Widimsky, P. Tomašov, 2015, Cardiology.

Carotid artery stenting – current status of the procedure

J. Veselka, M. Špaček, 2013, Archives of medical science : AMS.

Left ventricular pseudoaneurysm as a complication of myocardial infarction

J. Veselka, D. Černá, K. Linhartová, 2007 .

Intercoronary blood flow detected by color flow Doppler mapping is a well-known marker for anomalous origin of a coronary artery from the pulmonary trunk.

J. Veselka, 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy.

J. Veselka, P. Tomašov, D. Zemánek, 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

Reimplantation of anomalous right coronary artery arising from the pulmonary trunk leading to normal coronary flow reserve late after surgery.

J. Kautzner, J. Veselka, P. Widimsky, 2003, The Annals of thoracic surgery.

Percutaneous left ventricular pseudoaneurysm closure

J. Veselka, J. Fiedler, T. Hnat, 2020, Archives of medical science : AMS.

Relationship of C-reactive protein to adverse cardiovascular events in patients treated by percutaneous coronary intervention for stable angina pectoris.

J. Veselka, D. Tesař, Šárka Procházková, 2005, International heart journal.

Parathyroid hormone and vitamin D levels are independently associated with calcific aortic stenosis.

O. Topolcan, J. Veselka, J. Rácek, 2008, Circulation journal : official journal of the Japanese Circulation Society.

The role of near-infrared spectroscopy in the detection of vulnerable atherosclerotic plaques

J. Veselka, P. Hájek, J. Honěk, 2016, Archives of medical science : AMS.

Carotid Artery Stenting–Historical Context, Trends, and Innovations

J. Veselka, M. Špaček, 2015, International Journal of Angiology.

Comparison of carotid artery stenting in patients with single versus bilateral carotid artery disease and factors affecting midterm outcome.

J. Veselka, P. Hájek, P. Tomašov, 2011, Annals of vascular surgery.

History and current use of mild therapeutic hypothermia after cardiac arrest

J. Veselka, J. Honěk, J. Bonaventura, 2016, Archives of medical science : AMS.

Effect of stenting on the near-infrared spectroscopy-derived lipid core burden index of carotid artery plaque.

J. Veselka, P. Hájek, M. Horváth, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Intravascular Near-Infrared Spectroscopy: A Possible Tool for Optimizing the Management of Carotid Artery Disease

J. Veselka, P. Hájek, J. Honěk, 2015, International Journal of Angiology.

Deleterious Effects of Hyperactivity of the Renin-Angiotensin System and Hypertension on the Course of Chemotherapy-Induced Heart Failure after Doxorubicin Administration: A Study in Ren-2 Transgenic Rat

V. Melenovský, J. Veselka, P. Kala, 2020, International journal of molecular sciences.

Real-time myocardial contrast echocardiography for echo-guided alcohol septal ablation

J. Veselka, D. Zemánek, 2009 .

Takayasu arteritis: use of drug-eluting stent and balloon to treat recurring carotid restenosis.

J. Veselka, P. Zimolová, M. Špaček, 2012, The Journal of invasive cardiology.

Uncommon cause of obstruction in the left ventricular outflow tract by a metastasis of adenocarcinoma

J. Veselka, D. Zemánek, J. Ferda, 2010, Archives of medical science : AMS.

Long-term changes after carotid stenting assessed by intravascular ultrasound and near-infrared spectroscopy.

J. Veselka, P. Hájek, R. Roland, 2021, Cardiovascular diagnosis and therapy.

Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry

H. Bundgaard, J. Veselka, J. T. ten Berg, 2020, Archives of medical science : AMS.

Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.

J. Veselka, P. Hájek, M. Branny, 2013, International journal of cardiology.

Evaluation of the right ventricular function in hypertrophic obstructive cardiomyopathy: a strain and tissue Doppler study.

J. Veselka, P. Tomašov, D. Zemánek, 2010, Physiological research.

CORONARY ARTERY DISEASE Original Studies Long-Term Health Outcome and Mortality Evaluation After Invasive Coronary Treatment Using Drug Eluting Stents with or without the IVUS Guidance. Randomized Control Trial. HOME DES IVUS

J. Veselka, P. Kala, J. Jager, 2010 .

Composition of carotid artery stenosis and restenosis: A series of patients assessed with intravascular ultrasound and near-infrared spectroscopy.

J. Veselka, P. Hájek, M. Horváth, 2016, International journal of cardiology.

Near-infrared spectroscopy combined with intravascular ultrasound in carotid arteries

J. Veselka, P. Hájek, M. Horváth, 2015, The International Journal of Cardiovascular Imaging.

PEDIATRIC AND CONGENITAL HEART DISEASE Original Studies Complications of Low-Dose, Echo-Guided Alcohol Septal Ablation

J. Veselka, P. Tomašov, D. Zemánek, 2010 .

Impact of coexisting multivessel coronary artery disease on short-term outcomes and long-term survival of patients treated with carotid stenting

J. Veselka, P. Hájek, M. Horváth, 2016, Archives of medical science : AMS.

Mid-term outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in patients with sigmoid versus neutral ventricular septum.

J. Veselka, P. Tomašov, D. Zemánek, 2012, The Journal of invasive cardiology.

Evaluation of cerebrovascular reserve in patients undergoing carotid artery stenting and its usefulness in predicting significant hemodynamic changes during temporary carotid occlusion.

J. Veselka, P. Hájek, M. Horváth, 2016, Physiological research.

Transcranial Doppler Ultrasound in the Current Era of Carotid Artery Stenting

J. Veselka, V. Sorrell, M. Špaček, 2014, Ultraschall in der Medizin.

Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy

J. Veselka, J. Krejčí, D. Zemánek, 2013, TheScientificWorldJournal.

Feasibility, safety, and early outcomes of direct carotid artery stent implantation with use of the FilterWire EZ™ Embolic Protection System

J. Veselka, P. Hájek, D. Zemánek, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Patent Foramen Ovale Closure Is Effective in Divers: Long-Term Results From the DIVE-PFO Registry.

J. Veselka, L. Šefc, A. Tomek, 2020, Journal of the American College of Cardiology.

H. Bundgaard, J. Veselka, P. Hansen, 2021, JACC. Cardiovascular interventions.

The biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

J. Veselka, D. Zemánek, D. Tesař, 2004, Kardiologia polska.

The Paramount Role of the Anterior Communicating Artery in the Collateral Cerebral Circulation

J. Veselka, D. Tesař, M. Špaček, 2014, International Journal of Angiology.

Carotid artery plaque composition and distribution: near-infrared spectroscopy and intravascular ultrasound analysis

J. Veselka, P. Hájek, J. Honěk, 2020, European heart journal supplements : journal of the European Society of Cardiology.

Hypertrophic Cardiomyopathy Is at Increased Risk of Thromboembolic Events: Deficiencies of CHA2DS2-VASC Score and How to Predict.

J. Veselka, 2019, The Canadian journal of cardiology.

Optical Coherence Tomography of the Coronary Arteries

J. Veselka, R. Roland, 2021, International Journal of Angiology.

First-in-man near-infrared spectroscopy proof of lipid-core embolization during carotid artery stenting

J. Muller, J. Veselka, P. Hájek, 2016, Archives of medical science : AMS.

The lack of endothelization after drug-eluting stent implantation as a cause of fatal late stent thrombosis

Pavel Červinka, J. Veselka, P. Kala, 2008, Journal of Thrombosis and Thrombolysis.

Three-Dimensional Heart Printing for Planning of Septal Reduction Therapy in Patients with Hypertrophic Obstructive Cardiomyopathy

J. Veselka, T. Bartel, T. Adla, 2018, International Journal of Angiology.

Esophageal achalasia compressing the heart diagnosed by echocardiography.

J. Veselka, M. Mates, J. Bělohlávek, 1998, International journal of cardiology.

Pressure gradient response after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.

J. Veselka, 2006, Kardiologia polska.

Fibromuscular Dysplasia of Renal and Carotid Arteries

J. Veselka, Denisa Jahnlová, 2015, International Journal of Angiology.

Clinical pre-test probability for obstructive coronary artery disease: insights from the European DISCHARGE pilot study

P. Schlattmann, M. Gutberlet, L. Saba, 2020, European Radiology.

Outcomes of Alcohol Septal Ablation in Patients with Severe Left Ventricular Outflow Tract Obstruction: A Propensity Score Matching Analysis.

R. Stables, J. Veselka, J. T. ten Berg, 2023, The Canadian journal of cardiology.

Catheter-based management of a carotid artery injury by stent-graft implantation

J. Veselka, R. Pádr, D. Tesař, 2007 .

Mechanical Chest Compressions in Prolonged Cardiac Arrest due to ST Elevation Myocardial Infarction Can Cause Myocardial Contusion

J. Veselka, P. Hájek, C. Štěchovský, 2015, International Journal of Angiology.

Mid‐term outcomes of carotid artery stenting in patients with angiographic string sign

J. Veselka, P. Zimolová, L. Martinkovičová, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of mid-term outcomes of carotid artery stenting for moderate versus critical stenosis

J. Veselka, P. Hájek, P. Tomašov, 2011, Archives of medical science : AMS.

Outcome of resynchronization therapy on superficial and endocardial electrophysiological findings.

V. Suchánek, L. Lhotská, J. Veselka, 2018, Physiological research.

Subacute stent thrombosis associated with high residual platelet activity

J. Veselka, P. Hájek, I. Hadačová, 2009 .

Thirty-day outcomes of direct carotid artery stenting with cerebral protection in high-risk patients.

J. Veselka, P. Hájek, D. Zemánek, 2007, Circulation journal : official journal of the Japanese Circulation Society.

Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome

M. Aschermann, M. Penicka, V. Lánská, 2015, Molecular Biology Reports.

Association between a marker on chromosome 9 and acute coronary syndrome. confirmatory study on Czech population.

M. Aschermann, M. Penicka, V. Lánská, 2012, Folia biologica.